Ready-to-use stabilized SPIKE SARS COV-2 saRNA (E484K; N501Y)
Spike SARS-CoV-2 saRNAs have been designed to produce high expression level of SPIKE SARS COV-2 (E484K; N501Y) protein with enhanced length of duration. saRNAs are produced by in vitro transcription. saRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3’ end. Sequences have been optimized to yield improved stability and performance.
Spike SARS-CoV-2 saRNAs are also available capped with ExploCap™ upon request.
Spike SARS-CoV-2 self-amplifying RNA has been constructed based on replicons of positive-sense ((+)-RNA) viruses (Venezuelan equine encephalitis Virus (VEEV)), where the coding sequence of the viral structural proteins is replaced with that of a gene of interest (GOI, here SPIKE SARS COV-2 (E484K; N501Y)), while retaining the coding sequences of non-structural proteins (nsPs), including the viral RNA-dependent RNA polymerase. Please note that OZB saRNAs encodes also for Puromycin Resistance Cassette, which does not alter the expression of the GOI but can be used for cell selection.
mRNA length: 12911 nt.
Size: 20µg, 100µg and 1mg
Storage: saRNAs must be stored at -80°C. We recommend to aliquot the RNA solution for a better storage and avoid freeze/thaw cycles.
For Bulk, please contact us : order@ozbiosciences.com
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| MRNA78-20 |
20µg (unmodified)
|
$120.00
|
|
| MRNA78-100 |
100µg (unmodified)
|
$375.00
|
|
| MRNA78-1000 |
1mg (unmodified)
|
$1,975.00
|
|
| MRNA79-20 |
20µg (m5C)
|
$170.00
|
|
| MRNA79-100 |
100µg (m5C)
|
$400.00
|
|
| MRNA79-1000 |
1mg (m5C)
|
$2,075.00
|
|
Related products